NEXGEL, INC. Repayments of Convertible Debt
NEXGEL, INC. (NXGL) reported Repayments of Convertible Debt of $3.51 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2024-04-10
- NEXGEL, INC. repayments of convertible debt for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- NEXGEL, INC. repayments of convertible debt for the quarter ending 2021-12-31 was $0.00.
- NEXGEL, INC. repayments of convertible debt for the quarter ending 2021-09-30 was $0.00.
- NEXGEL, INC. repayments of convertible debt for the quarter ending 2021-06-30 was $0.00.
- NEXGEL, INC. repayments of convertible debt for fiscal 2022 was $3.51M, a 3411.00% increase from fiscal 2021.
- NEXGEL, INC. repayments of convertible debt for fiscal 2021 was $100.00K.
- NEXGEL, INC. repayments of convertible debt for fiscal 2020 was $0.00.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $3.51M 10-K · filed 2024-04-10 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 derived: sum of 3 quarters · filed 2023-03-28 | $0.00 derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 derived: sum of 2 quarters · filed 2023-03-28 | $0.00 derived: sum of 3 quarters · filed 2023-03-28 | $100.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $100.00K 10-Q · filed 2022-11-08 | $100.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $100.00K 10-Q · filed 2022-08-10 | $100.00K derived: sum of 3 quarters · filed 2022-08-10 | $100.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-13 | $100.00K derived: sum of 2 quarters · filed 2022-05-13 | $100.00K derived: sum of 3 quarters · filed 2022-05-13 | $100.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $0.00 derived: sum of 2 quarters · filed 2022-03-21 | $0.00 derived: sum of 3 quarters · filed 2022-03-21 | $0.00 10-K · filed 2022-03-21 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |